{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:01:36Z","timestamp":1794373296351,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41590-024-02051-0","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:03:35Z","timestamp":1738040615000},"page":"265-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots"],"prefix":"10.1038","volume":"26","author":[{"given":"Jinmin","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingli","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7712-6050","authenticated-orcid":false,"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengkun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoshun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoju","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-4732","authenticated-orcid":false,"given":"Jianxun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9076-2647","authenticated-orcid":false,"given":"Kefang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-4959","authenticated-orcid":false,"given":"Shuguang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-6398","authenticated-orcid":false,"given":"Yingze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4884-5780","authenticated-orcid":false,"given":"Jikun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3624-2514","authenticated-orcid":false,"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-615X","authenticated-orcid":false,"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-4070","authenticated-orcid":false,"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"2051_CR1","unstructured":"WHO COVID-19 Dashboard (World Health Organization, 2024); https:\/\/covid19.who.int\/"},{"key":"2051_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","volume":"186","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186, 279\u2013286.e8 (2023).","journal-title":"Cell"},{"key":"2051_CR3","unstructured":"Tracking of hCoV-19 Variants (GISAID, 2024); https:\/\/gisaid.org\/hcov19-variants\/"},{"key":"2051_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"2051_CR5","volume":"9","author":"MS Alam","year":"2023","unstructured":"Alam, M. S. Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities. Heliyon 9, e13285 (2023).","journal-title":"Heliyon"},{"key":"2051_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/v15010101","volume":"15","author":"ME Emmelot","year":"2022","unstructured":"Emmelot, M. E. et al. SARS-CoV-2 Omicron BA.4\/BA.5 mutations in spike leading to T cell escape in recently vaccinated individuals. Viruses 15, 101 (2022).","journal-title":"Viruses"},{"key":"2051_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cels.2021.09.013","volume":"13","author":"DJ Hamelin","year":"2022","unstructured":"Hamelin, D. J. et al. The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner. Cell Syst. 13, 143\u2013157.e3 (2022).","journal-title":"Cell Syst."},{"key":"2051_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34033-x","volume":"14","author":"OV Stanevich","year":"2023","unstructured":"Stanevich, O. V. et al. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Nat. Commun. 14, 149 (2023).","journal-title":"Nat. Commun."},{"key":"2051_CR9","doi-asserted-by":"crossref","first-page":"109708","DOI":"10.1016\/j.celrep.2021.109708","volume":"36","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants. Cell Rep. 36, 109708 (2021).","journal-title":"Cell Rep."},{"key":"2051_CR10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chom.2023.11.010","volume":"32","author":"A Sette","year":"2024","unstructured":"Sette, A., Sidney, J. & Grifoni, A. Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86. Cell Host Microbe 32, 19\u201324 (2024).","journal-title":"Cell Host Microbe"},{"key":"2051_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chom.2023.12.010","volume":"32","author":"TR M\u00fcller","year":"2024","unstructured":"M\u00fcller, T. R. et al. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant. Cell Host Microbe 32, 156\u2013161 (2024).","journal-title":"Cell Host Microbe"},{"key":"2051_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2023.12.003","volume":"32","author":"R Nesamari","year":"2024","unstructured":"Nesamari, R. et al. Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant. Cell Host Microbe 32, 162\u2013169 (2024).","journal-title":"Cell Host Microbe"},{"key":"2051_CR13","volume":"300","author":"S Deng","year":"2024","unstructured":"Deng, S. et al. Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants. J. Biol. Chem. 300, 107563 (2024).","journal-title":"J. Biol. Chem."},{"key":"2051_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9, 1 (2008).","journal-title":"BMC Immunol."},{"key":"2051_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.0001-2815.2004.00234.x","volume":"63","author":"D Middleton","year":"2004","unstructured":"Middleton, D. et al. HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing. Tissue Antigens 63, 555\u2013561 (2004).","journal-title":"Tissue Antigens"},{"key":"2051_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-2836(84)90309-7","volume":"179","author":"D Eisenberg","year":"1984","unstructured":"Eisenberg, D., Schwarz, E., Komaromy, M. & Wall, R. Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179, 125\u2013142 (1984).","journal-title":"J. Mol. Biol."},{"key":"2051_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2006.03.152","volume":"344","author":"Y-P Tsao","year":"2006","unstructured":"Tsao, Y.-P. et al. HLA-A*0201 T cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem. Biophys. Res. Commun. 344, 63\u201371 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2051_CR18","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.vaccine.2009.04.001","volume":"27","author":"S Ohno","year":"2009","unstructured":"Ohno, S. et al. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice. Vaccine 27, 3912\u20133920 (2009).","journal-title":"Vaccine"},{"key":"2051_CR19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2021","unstructured":"Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 22, 74\u201385 (2021).","journal-title":"Nat. Immunol."},{"key":"2051_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102096","volume":"24","author":"C Szeto","year":"2021","unstructured":"Szeto, C. et al. The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule. iScience 24, 102096 (2021).","journal-title":"iScience"},{"key":"2051_CR21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42430-z","volume":"14","author":"C Choy","year":"2023","unstructured":"Choy, C. et al. SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. Nat. Commun. 14, 6725 (2023).","journal-title":"Nat. Commun."},{"key":"2051_CR22","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/S2666-5247(23)00411-1","volume":"5","author":"P Du","year":"2024","unstructured":"Du, P. et al. The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2. Lancet Microbe 5, e516 (2024).","journal-title":"Lancet Microbe"},{"key":"2051_CR23","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect. Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"2051_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.medj.2024.03.006","volume":"5","author":"Q He","year":"2024","unstructured":"He, Q. et al. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies. Med 5, 401\u2013413.e4 (2024).","journal-title":"Med"},{"key":"2051_CR25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","volume":"187","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell 187, 596\u2013608.e17 (2024).","journal-title":"Cell"},{"key":"2051_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","volume":"187","author":"P Qu","year":"2024","unstructured":"Qu, P. et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell 187, 585\u2013595.e6 (2024).","journal-title":"Cell"},{"key":"2051_CR27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-023-00631-2","volume":"10","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide. Cell Discov. 10, 6 (2024).","journal-title":"Cell Discov."},{"key":"2051_CR28","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Rep. Med. 2, 100355 (2021).","journal-title":"Cell Rep. Med."},{"key":"2051_CR29","doi-asserted-by":"crossref","first-page":"100651","DOI":"10.1016\/j.xcrm.2022.100651","volume":"3","author":"P Garcia-Valtanen","year":"2022","unstructured":"Garcia-Valtanen, P. et al. SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents. Cell Rep. Med. 3, 100651 (2022).","journal-title":"Cell Rep. Med."},{"key":"2051_CR30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1073\/pnas.1322229111","volume":"111","author":"S Qui\u00f1ones-Parra","year":"2014","unstructured":"Qui\u00f1ones-Parra, S. et al. Preexisting CD8+ T cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc. Natl Acad. Sci. USA 111, 1049\u20131054 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2051_CR31","doi-asserted-by":"crossref","first-page":"866407","DOI":"10.3389\/fgene.2023.866407","volume":"14","author":"E Arrieta-Bola\u00f1os","year":"2023","unstructured":"Arrieta-Bola\u00f1os, E., Hern\u00e1ndez-Zaragoza, D. I. & Barquera, R. An HLA map of the world: a comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II. Front. Genet. 14, 866407 (2023).","journal-title":"Front. Genet."},{"key":"2051_CR32","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 48, D783\u2013D788 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2051_CR33","volume":"12","author":"S Lu","year":"2021","unstructured":"Lu, S. et al. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat. Commun. 12, 502 (2021).","journal-title":"Nat. Commun."},{"key":"2051_CR34","doi-asserted-by":"crossref","unstructured":"Kumar, A. et al. Characterization of nucleocapsid (N) protein from novel coronavirus SARS-CoV-2. Preprint at ResearchGate https:\/\/www.researchgate.net\/publication\/341671040 (2020).","DOI":"10.20944\/preprints202005.0413.v1"},{"key":"2051_CR35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101065","volume":"297","author":"P Chaurasia","year":"2021","unstructured":"Chaurasia, P. et al. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J. Biol. Chem. 297, 101065 (2021).","journal-title":"J. Biol. Chem."},{"key":"2051_CR36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","volume":"54","author":"THO Nguyen","year":"2021","unstructured":"Nguyen, T. H. O. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity 54, 1066\u20131082 (2021).","journal-title":"Immunity"},{"key":"2051_CR37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-024-01876-3","volume":"9","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents. Signal Transduct. Target. Ther. 9, 160 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2051_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34180-1","volume":"13","author":"S Swaminathan","year":"2022","unstructured":"Swaminathan, S. et al. Ablation of CD8+ T cell recognition of an immunodominant epitope in SARS-CoV-2 Omicron variants BA.1, BA.2 and BA.3. Nat. Commun. 13, 6387 (2022).","journal-title":"Nat. Commun."},{"key":"2051_CR39","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.cell.2022.07.002","volume":"185","author":"G Dolton","year":"2022","unstructured":"Dolton, G. et al. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Cell 185, 2936\u20132951.e19 (2022).","journal-title":"Cell"},{"key":"2051_CR40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/infdis\/jiw471","volume":"214","author":"WJ Liu","year":"2016","unstructured":"Liu, W. J. et al. Cross-immunity against avian influenza A(H7N9) virus in the healthy population is affected by antigenicity-dependent substitutions. J. Infect. Dis. 214, 1937\u20131946 (2016).","journal-title":"J. Infect. Dis."},{"key":"2051_CR41","doi-asserted-by":"crossref","first-page":"112827","DOI":"10.1016\/j.celrep.2023.112827","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity. Cell Rep. 42, 112827 (2023).","journal-title":"Cell Rep."},{"key":"2051_CR42","volume":"92","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. CD8+ T cell response-associated evolution of hepatitis B virus core protein and disease progress. J. Virol. 92, e02120-17 (2018).","journal-title":"J. Virol."},{"key":"2051_CR43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","volume":"608","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature 608, 603\u2013608 (2022).","journal-title":"Nature"},{"key":"2051_CR44","doi-asserted-by":"crossref","first-page":"11275","DOI":"10.1128\/JVI.01571-15","volume":"89","author":"HM Machkovech","year":"2015","unstructured":"Machkovech, H. M., Bedford, T., Suchard, M. A. & Bloom, J. D. Positive selection in CD8+ T cell epitopes of influenza virus nucleoprotein revealed by a comparative analysis of human and swine viral lineages. J. Virol. 89, 11275\u201311283 (2015).","journal-title":"J. Virol."},{"key":"2051_CR45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bsheal.2024.07.005","volume":"6","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Biosafety and immunology: an interdisciplinary field for health priority. Biosaf. Health 6, 310\u2013318 (2024).","journal-title":"Biosaf. Health"},{"key":"2051_CR46","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1084\/jem.20071261","volume":"204","author":"NJ Maness","year":"2007","unstructured":"Maness, N. J. et al. AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J. Exp. Med. 204, 2505\u20132512 (2007).","journal-title":"J. Exp. Med."},{"key":"2051_CR47","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3663","volume":"4","author":"SA Valkenburg","year":"2013","unstructured":"Valkenburg, S. A. et al. Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides. Nat. Commun. 4, 2663 (2013).","journal-title":"Nat. Commun."},{"key":"2051_CR48","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu, D. et al. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T cell receptors. Nat. Commun. 13, 19 (2022).","journal-title":"Nat. Commun."},{"key":"2051_CR49","volume":"16","author":"SA Johnson","year":"2021","unstructured":"Johnson, S. A. et al. Impact of HLA type, age and chronic viral infection on peripheral T cell receptor sharing between unrelated individuals. PLoS ONE 16, e0249484 (2021).","journal-title":"PLoS ONE"},{"key":"2051_CR50","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.immuni.2022.08.003","volume":"55","author":"C Saggau","year":"2022","unstructured":"Saggau, C. et al. The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination. Immunity 55, 1924\u20131939 (2022).","journal-title":"Immunity"},{"key":"2051_CR51","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1093\/cid\/ciab884","volume":"75","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. One-year sustained cellular and humoral immunities in coronavirus disease 2019 (COVID-19) convalescents. Clin. Infect. Dis. 75, e1072\u2013e1081 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"2051_CR52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.molimm.2019.06.005","volume":"112","author":"W Ji","year":"2019","unstructured":"Ji, W. et al. Salt bridge-forming residues positioned over viral peptides presented by MHC class I impacts T cell recognition in a binding-dependent manner. Mol. Immunol. 112, 274\u2013282 (2019).","journal-title":"Mol. Immunol."},{"key":"2051_CR53","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/eji.201343417","volume":"43","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Conserved epitopes dominate cross-CD8+ T cell responses against influenza A H1N1 virus among Asian populations. Eur. J. Immunol. 43, 2055\u20132069 (2013).","journal-title":"Eur. J. Immunol."},{"key":"2051_CR54","doi-asserted-by":"crossref","first-page":"113609","DOI":"10.1016\/j.celrep.2023.113609","volume":"43","author":"M Li","year":"2023","unstructured":"Li, M. et al. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population. Cell Rep. 43, 113609 (2023).","journal-title":"Cell Rep."},{"key":"2051_CR55","doi-asserted-by":"crossref","first-page":"e01024-18","DOI":"10.1128\/JVI.01024-18","volume":"92","author":"M Zhao","year":"2018","unstructured":"Zhao, M. et al. Prolonged evolution of virus-specific memory T cell immunity after severe avian influenza A (H7N9) virus infection. J. Virol. 92, e01024-18 (2018).","journal-title":"J. Virol."},{"key":"2051_CR56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/656315","volume":"202","author":"J Liu","year":"2010","unstructured":"Liu, J. et al. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J. Infect. Dis. 202, 1171\u20131180 (2010).","journal-title":"J. Infect. Dis."},{"key":"2051_CR57","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.177.4.2138","volume":"177","author":"M Zhou","year":"2006","unstructured":"Zhou, M. et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J. Immunol. 177, 2138\u20132145 (2006).","journal-title":"J. Immunol."},{"key":"2051_CR58","volume":"14","author":"D Lu","year":"2023","unstructured":"Lu, D. et al. KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors. Nat. Commun. 14, 6389 (2023).","journal-title":"Nat. Commun."},{"key":"2051_CR59","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.3390\/cells11244017","volume":"11","author":"L Feng","year":"2022","unstructured":"Feng, L. et al. The parallel presentation of two functional CTL epitopes derived from the O and Asia 1 serotypes of foot-and-mouth disease virus and swine SLA-2*HB01: implications for universal vaccine development. Cells 11, 4017 (2022).","journal-title":"Cells"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02051-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:15:33Z","timestamp":1738325733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-02051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1038\/s41590-024-02051-0","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}